Patient-reported outcome measures after metabolic surgery

Geltrude Mingrone¹, Lidia Castagneto-Gissey², Stefan R Bornstein³

Affiliations

¹ Università Cattolica del Sacro Cuore, Rome, Italy; Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy; Division of Diabetes & Nutritional Sciences, School of Cardiovascular and Metabolic Medicine & Sciences, King's College London, London, UK. Electronic address: geltrude.mingrone@kcl.ac.uk.
² Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy.
³ Division of Diabetes & Nutritional Sciences, School of Cardiovascular and Metabolic Medicine & Sciences, King's College London, London, UK; Department of Medicine III, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Dresden, Germany.

PMID: 37414072
DOI: 10.1016/S2213-8587(23)00173-0

Comment

Patient-reported outcome measures after metabolic surgery

Geltrude Mingrone et al. Lancet Diabetes Endocrinol. 2023 Aug.

. 2023 Aug;11(8):527-529.

doi: 10.1016/S2213-8587(23)00173-0. Epub 2023 Jul 3.

Authors

Geltrude Mingrone¹, Lidia Castagneto-Gissey², Stefan R Bornstein³

Affiliations

¹ Università Cattolica del Sacro Cuore, Rome, Italy; Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy; Division of Diabetes & Nutritional Sciences, School of Cardiovascular and Metabolic Medicine & Sciences, King's College London, London, UK. Electronic address: geltrude.mingrone@kcl.ac.uk.
² Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy.
³ Division of Diabetes & Nutritional Sciences, School of Cardiovascular and Metabolic Medicine & Sciences, King's College London, London, UK; Department of Medicine III, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Dresden, Germany.

PMID: 37414072
DOI: 10.1016/S2213-8587(23)00173-0

No abstract available

PubMed Disclaimer

Conflict of interest statement

GM reports consulting fees from Novo Nordisk, Fractyl, and Recor. She is also scientific advisor of Metadeq, Keyron, GHP Scientific, and Jemyll. LCG and SRB declare no competing interests.

Comment on

Patient-reported outcomes, weight loss, and remission of type 2 diabetes 3 years after gastric bypass and sleeve gastrectomy (Oseberg); a single-centre, randomised controlled trial.
Svanevik M, Lorentzen J, Borgeraas H, Sandbu R, Seip B, Medhus AW, Hertel JK, Kolotkin RL, Småstuen MC, Hofsø D, Hjelmesæth J. Svanevik M, et al. Lancet Diabetes Endocrinol. 2023 Aug;11(8):555-566. doi: 10.1016/S2213-8587(23)00127-4. Epub 2023 Jul 3. Lancet Diabetes Endocrinol. 2023. PMID: 37414071 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Patient-reported outcome measures after metabolic surgery

Affiliations

Patient-reported outcome measures after metabolic surgery

Authors

Affiliations

Conflict of interest statement

Comment on

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical